Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two consecutive days, ...

The anticipated IPO price for the Class A Ordinary Shares is expected to be between US$4 and US$5 per share. Prior to the IPO, there has been no public market for RCHL's Class A Ordinary Shares. The ...

Q2 2025 Earnings Call Transcript February 13, 2025 Operator: Welcome to the S&W Seed Company Second Quarter Fiscal Year 2025 ...

Edward Chung; Vice President - Investor Relations; Bio Rad Laboratories Inc. Unidentified Company Representative. Roop Lakkaraju; Chief Financial Officer, Executive ...

PBF Energy's crack spreads need to double from Q4 levels for PBF to achieve neutral free cash flow, which seems unlikely in ...

Mark Herrmann; President, Chief Executive Officer; S&W Seed Co Vanessa Baughman; Chief Financial Officer, Corporate Secretary; S&W Seed Co All right. Thank you very much, and thank you all for joining ...

"2. Yalta 2.0" agreement among major powers, particularly distancing European nations from these essential negotiations. This ...

Our journalists and analysts have extensive experience in market analysis and blockchain technologies ... due to Trump’s pro-cryptocurrency stance and promises of a favorable regulatory environment.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...